Skip to content

Ametek Inc/ (AME) stock: revenue, earnings & dividend

Ametek Inc/ (AME, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener AME · NYSE Medizintechnik & Messgeräte US-PA

Key figures

Fiscal year
2025
Revenue
7.4 bn $
Revenue growth
6.6 %
Revenue growth 5y (p.a.)
–
Net income
1.48 bn $
Net margin
20 %
Operating margin
25.8 %
Earnings per share (diluted)
6.40 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
16.1 bn $
Equity
10.6 bn $
Equity ratio
66.2 %
Return on equity
13.9 %
Cash
458 m $
Operating cash flow
1.8 bn $
Free cash flow
1.67 bn $
Shares outstanding
229,317,998

History

Revenue by fiscal year

2016 3.84 bn $
2017 4.3 bn $
2022 6.15 bn $
2023 6.6 bn $
2024 6.94 bn $
2025 7.4 bn $

Net income by fiscal year

2016 512 m $
2017 681 m $
2018 778 m $
2019 861 m $
2020 872 m $
2021 990 m $
2022 1.16 bn $
2023 1.31 bn $
2024 1.38 bn $
2025 1.48 bn $

Dividend per share

2016 0.36 $
2017 0.36 $
2018 0.56 $
2019 0.56 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20257.4 bn $1.48 bn $6.40 $–1.8 bn $
20246.94 bn $1.38 bn $5.93 $–1.83 bn $
20236.6 bn $1.31 bn $5.67 $–1.74 bn $
20226.15 bn $1.16 bn $5.01 $–1.15 bn $
2021–990 m $4.25 $–1.16 bn $
2020–872 m $3.77 $–1.28 bn $
2019–861 m $3.75 $0.56 $1.11 bn $
2018–778 m $3.34 $0.56 $926 m $
20174.3 bn $681 m $2.94 $0.36 $833 m $
20163.84 bn $512 m $2.19 $0.36 $757 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)